Health Status of Transgender Women in French Guiana and Paris (TransGuyane)

NCT04962997 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 46

Last updated 2023-10-17

No results posted yet for this study

Summary

Assessing and comparing the life and health status of transgender or trans women in French Guiana and Paris. Conducting a questionnaire on physical, mental and sexual health, migration history, transition, and STI screening.

Conditions

Interventions

OTHER

Data collection

Investigator will ensure the completion of a hetero-administered questionnaire which will be carried out in French, English, Portuguese or Spanish depending on the language spoken by the participant, including informations related to Demography and socio-economic conditions, Addictions, Work and studies, Housing, Health coverage, Gender and sexuality, Vulnerabilities and violence, Recourse to care, State of physical health, Mental Health, Prevention and Sexually Transmitted Infections (STIs), Checkup, Transition path and clinical complications and Dermatological problems. Investigator will collect the data relating to the clinical examination, dermatological examination and the search for STIs (blood and / or urine) carried out in the routine care of the participant in a case report form (CRF). The estimated duration of the interviews and the consultation is approximately 1 hour and 30 minutes per patient.

Sponsors & Collaborators

  • Bichat Hospital

    collaborator OTHER
  • Centre Hospitalier de Cayenne

    lead OTHER

Principal Investigators

  • Chloé BERTIN · Centre Hospitalier de Cayenne

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-06
Primary Completion
2022-10-19
Completion
2023-01-06

Countries

  • France
  • French Guiana

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04962997 on ClinicalTrials.gov